Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziegler, A.
Right arrow Articles by Rémy, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziegler, A.
Right arrow Articles by Rémy, C.
[Cancer Research 61, 5595-5600, July 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

High Glycolytic Activity in Rat Glioma Demonstrated in Vivo by Correlation Peak 1H Magnetic Resonance Imaging1

Anne Ziegler2, Markus von Kienlin3, Michel Décorps and Chantal Rémy

Unité mixte Institut National de la Santé et de la Recherche Médicale/Université Joseph Fourier: Unité 438 "RMN Bioclinique," Laboratoire de Recherche Correspondant du Commissariat à l’Energie Atomique, Centre Hospitalier Universitaire BP 217, 38043 Grenoble, France [A. Z., M. D., C. R.], and Physikalisches Institut V, Universität Würzburg, 97074 Würzburg, Germany [M. v. K.]

High-grade brain tumors are known to have a high rate of glucose (Glc) consumption. Postmortem measurements have suggested that Glc content in experimental brain tumors is relatively low. We used magnetic resonance spectroscopy to investigate this, in vivo, in the brains of seven rats bearing intracerebral C6 gliomas. We combined the high spectral resolution allowed by two-dimensional proton nuclear magnetic resonance with spatial encoding by magnetic field gradient pulses to obtain in vivo maps of Glc, alanine, hypotaurine, aspartate, phosphoethanolamine, Glu/Gln, N-acetylaspartate (NAA), phosphocreatine/creatine (PCr/Cr), choline-containing compounds, and lactate (Lac) (some of which are involved in energy metabolism). Compared with normal brain tissue, the main differences found in the gliomas were that Glc, NAA, PCr/Cr, and aspartate concentrations were much lower, whereas concentrations of alanine, hypotaurine, phosphoethanolamine, and Lac were higher, whatever the extent of necrosis. A striking observation is the similarity of the NAA and Glc images: the concentrations of both metabolites are lower in the tumor than they are in the contralateral brain. If Glc was completely absent from the tumor tissue, and if the residual Glc level was due only to a partial volume effect like that for NAA, a neuronal marker, the ratio [Glc]tumor/[Glc]contralateral tissue, should be similar to that found for NAA. The ratio for Glc was 0.48 ± 0.22 (± SD; n = 6), a ratio similar to that found for PCr/Cr (0.50 ± 0.19) but significantly higher than that obtained for NAA (0.29 ± 0.07). This observation indicates that a measurable Glc concentration is still present in the tumor tissue. Intense glycolysis in tumor cells may explain the increased production of Lac and alanine and decreased amount of Glc. These nuclear magnetic resonance measurements of metabolite concentrations are complementary to positron emission tomography, which measures Glc consumption.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
V. Garcia-Escudero, R. Gargini, and M. Izquierdo
Glioma Regression In vitro and In vivo by a Suicide Combined Treatment
Mol. Cancer Res., March 1, 2008; 6(3): 407 - 417.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Drogat, P. Auguste, D. T. Nguyen, M. Bouchecareilh, R. Pineau, J. Nalbantoglu, R. J. Kaufman, E. Chevet, A. Bikfalvi, and M. Moenner
IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth In vivo
Cancer Res., July 15, 2007; 67(14): 6700 - 6707.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-K. Shin, B. C. Yoo, H. J. Chang, E. Jeon, S.-H. Hong, M.-S. Jung, S.-J. Lim, and J.-G. Park
Down-regulation of Mitochondrial F1F0-ATP Synthase in Human Colon Cancer Cells with Induced 5-Fluorouracil Resistance
Cancer Res., April 15, 2005; 65(8): 3162 - 3170.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. M. Cuezva, M. Krajewska, M. L. de Heredia, S. Krajewski, G. Santamaria, H. Kim, J. M. Zapata, H. Marusawa, M. Chamorro, and J. C. Reed
The Bioenergetic Signature of Cancer: A Marker of Tumor Progression
Cancer Res., November 15, 2002; 62(22): 6674 - 6681.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. A. Kunz-Schughart and J. P. Freyer
Phosphorous metabolites and steady-state energetics of transformed fibroblasts during three-dimensional growth
Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1287 - C1297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.